Showing results (691-700 of 721) with videos related to

Sort By:
Pageof 73
JCO Precision Oncology|September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic CancerEugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2017
4-1BB Agonist Focuses CD8+ Tumor-Infiltrating T-Cell Growth into a Distinct Repertoire Capable of Tumor Recognition in Pancreatic CancerDonastas Sakellariou-Thompson, Marie-Andrée Forget, Caitlin Creasy, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2010
Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonistsHai-Yun Xiao, Aaron Balog, Ricardo M Attar, et al.
International Journal of Molecular Sciences|December 17, 2024
Molecular Pathway and Immune Profile Analysis of IPMN-Derived Versus PanIN-Derived Pancreatic Ductal AdenocarcinomasMargaret A Park, Kristyn Gumpper-Fedus, Somashekar G Krishna, et al.
The Journal of Clinical Investigation|March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and responseEugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Cancer Research|March 5, 2015
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancerPiergiorgio Pettazzoni, Andrea Viale, Parantu Shah, et al.
The Journal of Clinical Investigation|October 25, 2022
3D imaging analysis on an organoid-based platform guides personalized treatment in pancreatic ductal adenocarcinomaYa'an Kang, Jenying Deng, Jianhua Ling, et al.
Cancer Medicine|May 11, 2019
Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequitiesJennifer B Permuth, Ashley Clark Daly, Daniel Jeong, et al.
Nature Cancer|February 5, 2022
APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasisSonja M Wörmann, Amy Zhang, Fredrik I Thege, et al.
Cancer|January 26, 2018
Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapyAhmed M Amer, Mohamed Zaid, Baishali Chaudhury, et al.
Pageof 73